1 / 17

Biochemical Markers for Diagnosis of Myocardial Infarction

Biochemical Markers for Diagnosis of Myocardial Infarction. What is Myocardial Infarction?. Myocardial ischemia results from the reduction of coronary blood flow to an extent that leads to insufficiency of oxygen supply to myocardial tissue

binah
Download Presentation

Biochemical Markers for Diagnosis of Myocardial Infarction

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Biochemical Markers for Diagnosis of Myocardial Infarction

  2. What isMyocardial Infarction? • Myocardial ischemia results from the reduction of coronary blood flow to an extent that leads to insufficiency of oxygen supply to myocardial tissue • When this ischemia is prolonged & irreversible, myocardial cell death & necrosis occurs ---this is defined as: Myocardial Infarction is the death & necrosis of myocardial cells as a result of coronary prolonged & irreversible ischemia

  3. Biochemical Changes in Acute Myocardial Infarction(mechanism of release of myocardial markers) ischemia to myocardial muscles (with low O2 supply) anaerobic glycolysis increased accumulation of Lactate decrease in pH activate lysosomal enzymes disintegration of myocardial proteins cell death & necrosis ECG changes clinical manifestations (chest pain) release of intracellular contents to blood BIOCHEMICAL MARKERS

  4. Diagnosis of Myocardial Infarction 1- Clinical Manifestations 2- ECG 3- Biochemical Markers

  5. Criteria of ideal markers for myocardial infarction 1- Specific: to myocardial muscle cells (no false positive) 2- Sensitive: - rapid release on onset of attack (diagnose early cases) - so, can detect minor damage - no miss of positive cases (no false negative) 3- Prognostic: relation between plasma level & extent of damage 4- Persists longer: so, can diagnose delayed admission 6- Reliable: procedure depends on evidenced principle 5- Simple, inexpensive: - can be performed anywhere by low costs - no need for highly qualified personnel 7- Quick: low turnaround time

  6. Types of Biochemical Markers for Diagnosis of Myocardial Infarction 1- Cardiac enzymes (isoenzymes): Total CK CK-MB activity CK-MB mass LDH AST 2- Cardiac proteins: Myoglobin Troponins

  7. Cardiac Enzymes • Total CK (sum of CK-MM, CK-MB & CK-BB) non specific to cardiac tissue (available also in skeletal muscles) • CK-MB (CK-2) activity More specific than total CK BUT: less specific than cardiac troponin I (as CK-MB is also available in skeletal muscles) Appears in blood: within 4 - 6 hours of onset of attack (used for early cases) Reaches maximum peak within: 12 - 24 hours Returns to normal: after 2 - 3 days of onset (nolong stay in blood. So, notfor delayed admissions) Advantages: - useful for earlydiagnosis of MI - useful for diagnosis reinfarction Disadvantages: notused for delayed admission (more than 2 days) not 100% specific (elevated in skeletal muscle damage)

  8. Cardiac Enzymes cont. • CK-MB mass -Appears one hour earlierthan CK-MB activity (more sensitive) - So, useful for diagnosis of early cases & reinfarction - BUT: notfor diagnosis of delayed admission cases & less specific than cardiac troponin I • Relative index = CK-MB mass / Total CK X 100 more than 5 % is indicative for MI

  9. Cardiac Enzymes cont. • Lactate dehydrogenase (LDH) LDH is a tetramer, each chain may be one of two types (H & M) where: LDH1 is (H4) while LD5 is (M4) 5 isomers are available, but, each predominates in a certain organ. LD1 & LD2 predominates in heart Detected in blood: 18-16 hours after onset of MI attacks (not for early cases) Reaches a maximum peak level: in 48 h Remains elevated for: 5-6 days after MI (may remain elevated up to 14 days) Disadvantages: A non-specific marker of as it is also elevated in diseases of liver, lung, kidney, RBCs etc

  10. Cardiac Enzymes cont. • Aspartate aminotransferase (AST) • A non-specific marker of MI as it appears also in liver & other organs diseases • (N.B. AST is somewhat more heart-specific than ALT) • Detected in blood: 6-12 hours after onset of MI attacks (not for early cases) • Reaches a maximum peak level: in 30 hours • Returns to normal : after 2 - 6 days after MI

  11. Cardiac Proteins • Myoglobin - Non specificfor cardiac tissue (as it is elevated also in skeletal muscle & renal tissue) - Appears in blood earlierthan other markers (within 1-4 hours) So, with high sensitivity - BUT: Returns to normal in 24 hours So, NOT for delayed admission cases (after one day of onset of attack)

  12. Cardiac Proteins cont. • Cardiac Troponins Protein complex located on the thin filament of striated muscles consists of 3 subunits: cTn T, cTn I & cTn C with different structures & functions cTnI & cTnTareused are biomarkers for MI diagnosis Cardiac troponins (cTn)are different from skeletal muscle troponins So, more specific for MI diagnosis

  13. Cardiac Proteins cont. • Cardiac Troponin I (cTn I) 100 % cardiac specific With greater sensitivityfor diagnosing minordamage of MI Appears in blood: within 6 hours after onset of infarction Reaches maximum peak: around 24 hours Disappears from blood: after about 10 days (stays longer) So, useful for diagnosis of delayed admission Prognostic marker : Matching relation between level in blood & extent of cardiac damage

  14. Recommendations for use of biochemical markers for diagnosis of myocardial infarction 1- Recommended for all patientscomplaining of chest pain (with clinical examination & ECG) 2- Sample Type: plasma Timing: i. on admission ii. serial ( at least every one hour in a period 6-9 hours) should be referenced to admission & onset of pain 3- Testshould be with low turnaround time Less than one hour (accepted) Less than half an hour is preferred 4-Types of Markers used: Early markers: as Myoglobin: Appears in blood early (within less 4 fours) BUT not specific & not persists for long period (less than 2 days) Definitive markers: Troponin: Appears in blood later than myoglobin (within 6 hours) BUT 100% specific, prognostic & stays longer (one week) 5- Troponinis currently the marker of choice should be available in all cardiac & emergency centers (if not, CK-MB mass is the second choice)

  15. Time Course for Biomarkers of Myocardial Infarction

  16. Diagnosis of Heart Failure • Heart failure is a complex clinical condition in which the heart ‘s ability to pump is compromised. • The prognosis is poor if untreated, with a two-year survival rate of under 50% • The diagnosis can be difficult, especially the presenting symptoms can be due to many diseases. • The definitive diagnosis is best by echocardiography ( which can be limited or delayed

  17. Diagnosis of Heart Failureb-natriuretic peptide (BNP) • BNP is a neurohormone secreted by cardiac myocytes in response to volume expansion & pressure overload , • It plays a role in circulatory homeostasis (natriuresis, diuresis & vasodilatation). • In heart failure, it increases. So we can differentiate between breathlessness due to cardiac disease or pulmonary cause. • The accuracy of its measurement is greatest in patients with more severe disease and poorest in those already receiving treatment

More Related